Litek Pharma at Farmaforum 2025
On September 17–18, 2025, Litek Pharma took part in the 11th edition of Farmaforum, held at Pavilion 9 of IFEMA Madrid. This leading event for the pharmaceutical, biotechnology, and laboratory technology industries brought together key players in an exhibition space complemented by specialized conferences and networking opportunities.
From our booth, we showcased solutions designed for sterile production environments, with a focus on safety, containment, and regulatory compliance:
Small-scale Fill & Finish isolators
Containment isolators
Isolators for Advanced Therapies
Isolators for aseptic processing
RABS for aseptic processing
Glove & RTP Tester
Material Transfer Systems (MTS)
These technologies address the current challenges in the manufacturing of biological medicines and advanced therapy medicinal products (ATMPs), where GMP standards demand increasingly controlled processes.
Challenges in ATMP Manufacturing: Javier Alonso’s Participation in the Biotechforum 2025 Roundtable
As part of the Biotechforum—an official component of Farmaforum—our CEO, Javier Alonso, joined the roundtable “Key Aspects in the Manufacturing of Biological Medicines and Advanced Therapies” alongside leading industry professionals:
Arturo Macarron Palacios (Business Development Center Heidelberg – GenCC GmbH & Co. KG)
Julio Font (CEO and Managing Director of Histocell, Regenerative Medicine)
Laura Yvars (Contamination Control Sales Manager, Tiselab)
Manuel Moreno (Business Development Manager, VALTRIA)
During his intervention, Javier Alonso discussed “Challenges in the Manufacturing of Advanced Therapy Medicinal Products under GMP Conditions”, highlighting key points such as:
The ongoing revision of Part IV of the GMP, expected to align in some key aspects with the new GMP Annex I requirements.
The regulatory push toward barrier systems, where the use of isolators and RABS is emerging as the best practice for ATMP manufacturing.
The critical features of isolators in this field:
Efficient and reproducible decontamination.
Control and monitoring of critical process parameters: tightness testing with automated leak tests in accordance with ISO 10648, monitoring of pressure, viable and non-viable particles, H₂O₂ concentration, airflow velocity in Grade A areas, etc.
Reduced risk of contamination.
Continuous monitoring and validation of process parameters.
This exchange of perspectives provided a broad and complementary view of the regulatory, technological, and operational challenges shaping the future of biological medicines and advanced therapy manufacturing.
Litek Pharma: Commitment to Innovation and Regulatory Compliance
Litek Pharma’s presence at Farmaforum 2025 reflects our commitment to innovation and expert support for the pharmaceutical and biotechnology industries.
We will continue to promote solutions that enable manufacturers to anticipate regulatory changes, enhance personnel safety and product quality, and successfully adapt to the challenges of future medicine.
